The association between desmopressin exposure, FVIII response and side effects

Haemophilia. 2021 Jul;27(4):e506-e509. doi: 10.1111/hae.14227. Epub 2020 Dec 13.

Authors

Lisette M Schütte¹, Reinier M van Hest², Marjon H Cnossen³, Sara C M Stoof¹, Frank W G Leebeek¹, Ron A A Mathôt², Marieke J H A Kruip¹

Affiliations

¹ Department of Haematology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
² Hospital Pharmacy - Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Rotterdam, The Netherlands.
³ Department of Paediatric Haematology, Erasmus MC, University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands.

PMID: 33314458
DOI: 10.1111/hae.14227

No abstract available

Keywords: bleeding; bleeding disorder; desmopressin; haemophilia A; pharmacokinetics.

Publication types

Letter

MeSH terms

Deamino Arginine Vasopressin* / adverse effects
Factor VIII
Hemophilia A* / drug therapy
Humans

Substances

Factor VIII
Deamino Arginine Vasopressin